Compass Therapeutics, Inc. (CMPX)
NASDAQ: CMPX · Real-Time Price · USD
1.840
+0.050 (2.79%)
At close: Apr 28, 2026, 4:00 PM EDT
1.830
-0.010 (-0.54%)
After-hours: Apr 28, 2026, 7:19 PM EDT
Compass Therapeutics Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Revenue | - | 0.85 | - | - | - | |
| Gross Profit | - | 0.85 | - | - | - | |
| Selling, General & Admin | 16.87 | 15.13 | 12.24 | 11.66 | 10.93 | |
| Research & Development | 55.97 | 42.34 | 38.12 | 30 | 20.34 | |
| Operating Expenses | 72.84 | 57.48 | 50.36 | 41.66 | 31.26 | |
| Operating Income | -72.84 | -56.63 | -50.36 | -41.66 | -31.26 | |
| Interest Expense | - | - | - | - | -0.37 | |
| Interest & Investment Income | 6.35 | 7.25 | 7.87 | 2.36 | 0.03 | |
| EBT Excluding Unusual Items | -66.49 | -49.38 | -42.49 | -39.3 | -31.61 | |
| Gain (Loss) on Sale of Assets | - | - | - | 0.07 | 0.04 | |
| Pretax Income | -66.49 | -49.38 | -42.49 | -39.23 | -82.18 | |
| Net Income | -66.49 | -49.38 | -42.49 | -39.23 | -82.18 | |
| Net Income to Common | -66.49 | -49.38 | -42.49 | -39.23 | -82.18 | |
| Shares Outstanding (Basic) | 158 | 137 | 127 | 105 | 63 | |
| Shares Outstanding (Diluted) | 158 | 137 | 127 | 105 | 63 | |
| Shares Change (YoY) | 14.78% | 8.15% | 20.76% | 67.31% | 104.28% | |
| EPS (Basic) | -0.42 | -0.36 | -0.33 | -0.37 | -1.31 | |
| EPS (Diluted) | -0.42 | -0.36 | -0.33 | -0.37 | -1.31 | |
| Free Cash Flow | -49.17 | -44.9 | -40.65 | -34.34 | -21.55 | |
| Free Cash Flow Per Share | -0.31 | -0.33 | -0.32 | -0.33 | -0.34 | |
| Gross Margin | - | 100.00% | - | - | - | |
| Operating Margin | - | -6661.76% | - | - | - | |
| Profit Margin | - | -5808.82% | - | - | - | |
| Free Cash Flow Margin | - | -5282.23% | - | - | - | |
| EBITDA | -72.56 | -56.04 | -49.66 | -40.87 | -30.7 | |
| D&A For EBITDA | 0.28 | 0.59 | 0.7 | 0.78 | 0.57 | |
| EBIT | -72.84 | -56.63 | -50.36 | -41.66 | -31.26 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.